ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2025

Feb 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2025-02-03

Reporting Person: Pratumsuwan Piratip (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-03	Stock Option (Right to Buy)	$10.56	A	51181	Acquired	2035-02-03	Common Stock (51181)	Direct
2025-02-03	Stock Option (Right to Buy)	$10.56	A	22443	Acquired	2035-02-03	Common Stock (22443)	Direct

Footnotes

F1: This option represents a right to purchase a total of 51,181 shares of Rocket Pharmaceutical, Inc. (the "Issuer")'s common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on February 3, 2028.

F2: This option represents a right to purchase a total of 22,443 shares of the Issuer's common stock, which will fully vest on February 3, 2026.